News Snapshot:
Arkray, a Japanese company that develops products that focus on diabetes testing and urine analysis, has launched a venture capital (CVC) company through a subsidiary in Singapore. The fund, called Arkray 4U, aims to support startups in the healthcare and related sectors in Japan, Southeast Asia, India and Israel. Its goal is to invest in and support healthcare startups that can leverage the parent company’s assets / resources to scale and grow. “We want to invest in what we call the broader healthcare sector. For example, digital healthcare, medtech, biotech, AI, IoT medical devices, cloud pharmacies, medical diagnostics, personal wellness...
